PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |diabetes |
| Sentences | 526 |
| PubMedID- 24379835 | Current evidence indicates that low vegetable consumption is associated with obesity, diabetes and higher risk of cardiovascular diseases and increased rate of some cancers. |
| PubMedID- 20431798 | As a strong relationship exists between all forms of vascular disease in patients with diabetes and hyperlipidemia, it is important to screen for and treat these lipid abnormalities. |
| PubMedID- 23593110 | The following risk categories that modify ldl-c goals were generated: less than 160 mg/dl (4.14 mmol/l) if low risk (0–1 risk factor), less than 130 mg/dl (3.37 mmol/l) if moderate risk (≥2 risk factors and framingham risk score 10–20%), less than 100 mg/dl (2.59 mmol/l) if high risk (cad or cad risk equivalents) and less than 70 mg/dl (1.81 mmol/l) for very high-risk patients (those who have had a recent heart attack, or have cardiovascular disease combined with diabetes). |
| PubMedID- 22933440 | (30), who found diabetes-related markers of cerebrovascular disease to be more pronounced among individuals in later stages of cognitive decline (i.e., with dementia). |
| PubMedID- 22111049 | However, the relationships between dpn and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes have not been fully investigated. |
| PubMedID- 20977287 | However, although antiplatelet therapy with low-dose aspirin has been reported to prevent vascular events in high-risk patients with cardiovascular disease, recent studies in patients with pad or diabetes mellitus have failed to support the efficacy of aspirin in preventing vascular events in these patient populations. |
| PubMedID- 20929995 | Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (glp-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the lifelink database. |
| PubMedID- 22447230 | This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the development of cardiovascular disease among individuals with diabetes mellitus. |
| PubMedID- 23306779 | Moreover, vascular insulin resistance negatively impacts vascular health by affecting blood pressure regulation, vessel wall inflammation and atherogenesis thereby contributing to the burden of vascular disease seen with diabetes and metabolic syndrome. |
| PubMedID- 24251228 | It is known that diabetes doubles the risk of various vascular diseases. |
| PubMedID- 21253508 | Although the results of the recent action to control cardiovascular disease in diabetes (accord) trial did not report side effects associated with the use of the fibrate class of ppar α agonists , other studies have reported that they can increase the risk for myopathy, cholelithiasis, and venous thrombosis . |
| PubMedID- 20825660 | Similarly, obesity and being overweight are risk factors for diseases such as type 2 diabetes, certain types of cancer and cardiovascular diseases, and affect between 30% and 80% of adults and up to one third of children 4. |
| PubMedID- 26239688 | Nevertheless, microalbuminuria is also a risk factor for cardiovascular disease in patients with or without diabetes and currently there exist no tests that can differentiate between these two potential causes . |
| PubMedID- 20580779 | Our results suggested that incorporation of almonds into a healthy diet has beneficial effects on adiposity, glycemic control, and the lipid profile, thereby potentially decreasing the risk for cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 22807666 | Impaired ca leads to more dependence of cbf on bp, leaving brain tissue unprotected against the potentially harmful effects of bp fluctuations, as demonstrated in cerebromicrovascular disease associated with diabetes , or after ischemic stroke – and brain injury –. |
| PubMedID- 24416433 | Several clinical studies were also performed to investigate the safety of dpp4 inhibitors on diabetes with cardiovascular disease. |
| PubMedID- 26221527 | Consistent with the present results, that report suggested that cd34+ cell counts might be a more useful clinical marker of cardiovascular disease progression in patients with diabetes than the number of epcs. |
| PubMedID- 25898207 | The atherosclerosis of large vessels is associated with macrovascular diseases in diabetes, which result in coronary artery diseases, stroke, and peripheral vascular diseases 2. |
| PubMedID- 26130877 | Winners in each category were as follows: best fellow poster, "diet pattern and cardiovascular disease among women with type 2 diabetes mellitus," by hyun joon shin, md; best resident poster, "oral squamous cell carcinoma: current concepts in imaging, staging, and fibular osteocutaneous free-flap reconstruction," by r. |
| PubMedID- 19398138 | To assess the role of diabetes in vascular disease we investigated the number and viability of circulating epcs and related this to endothelial function. |
| PubMedID- 22021772 | The excess risk of vascular disease in persons with diabetes is about twofold compared with those without diabetes and is independent of other conventional cardiovascular risk factors. |
| PubMedID- 21437092 | Proactive was a prospective, randomized controlled trial that included 5,238 patients with type 2 diabetes who had evidence of macrovascular disease. |
| PubMedID- 24102059 | Further data adjustment for age, gender, diabetes status, and history of past cardiovascular disease, dialysis vintage, and fmi did not substantially affect these results (table 5). |
| PubMedID- 21871097 | Background: the presence of microalbuminuria can be associated with overt nephropathy and cardiovascular disease in patients with type 1 diabetes (t1d). |
| PubMedID- 21359028 | although the metabolic syndrome unequivocally predisposes to type 2 diabetes mellitus, many investigators of cardiovascular diseases consider this syndrome a multidimensional risk factor for ascvd. |
| PubMedID- 26542673 | There is compelling observational evidence that higher levels of physical activity and cardio-respiratory fitness confers a substantial protection against mortality and premature cardiovascular disease in individuals with diabetes . |
| PubMedID- 23320535 | The hazard ratios for the relative risk of death from cardiovascular disease with respect to diabetes were estimated (table 3). |
| PubMedID- 26216409 | Despite the strong association with hyperglycaemia, several intervention trials looking at intensive glucose control failed to show reduction of macrovascular disease in patients with diabetes 7. |
| PubMedID- 26248341 | Overall, rage activation in vsmc could represent a keystone in the development of vascular diseases associated with diabetes by interfering with the contractile phenotype of vsmc through the modification of their mechanical and functional properties. |
| PubMedID- 24367528 | Around half of all deaths in those with type 2 diabetes are due to cardiovascular disease . |
| PubMedID- 26558824 | Questionnaires about hypertension, diabetes, hypercholesterolemia, family history of early-onset cardiovascular disease, smoking, alcohol consumption, and sedentary lifestyle were administered. |
| PubMedID- 26252223 | Dyslipidemia is a strong risk factor for cardiovascular disease among patients with type 2 diabetes (t2d). |
| PubMedID- 22402944 | To elucidate the pathogenesis of macrovascular disease in diabetes, animal models are widely used. |
| PubMedID- 25883983 | There are numerous cardiovascular diseases that occur in patients with diabetes, both type 1 or type 2. dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. |
| PubMedID- 21655762 | Concomitant with the clinical improvement in cp, a reduction was observed in the serum levels of il-6 and us-crp, both of which are markers of the systemic inflammatory response, in agreement with the results of other publications.10,13,20,21 considering that chronic inflammation is a risk factor for atherosclerotic cardiovascular disease in patients with hypertension and diabetes mellitus, the main causes of ckd, it is plausible that the immediate diagnosis of cp followed by pt should constitute an important preventive measure in the course of ckd in the everyday clinic. |
| PubMedID- 24582090 | Cardiovascular disease in diabetes mellitus: risk factors and medical therapy. |
| PubMedID- 21398276 | Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease. |
| PubMedID- 21078616 | The contribution of the hemostatic system in the development of cardiovascular disease (cvd) in patients with type 2 diabetes is not completely defined. |
| PubMedID- 21943205 | However, applying a score with a required 9 input variables (i.e., age, female, anemia, hypertension, diabetes, history of cardiovascular disease, congestive heart failure, peripheral vascular disease, and proteinuria) in clinical practice might not be as simple as suggested. |
| PubMedID- 24617860 | Context: dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus (dm). |
| PubMedID- 24627825 | Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 22427765 | Microangiopathic and macroangiopathic disturbances may be prognostic for the course of muscle vascular diseases in patients with diabetes, and numerous observations suggest the presence of a common pathological mechanism of disturbance. |
| PubMedID- 20380625 | Type 2 diabetes (t2d) is associated with increased cardiovascular disease and mortality. |
| PubMedID- 21411509 | A mild-to-moderate reduction of egfr predicts cardiovascular disease in patients with type 2 diabetes, also independently of classic risk factors (24). |
| PubMedID- 24344928 | Logistic regression was used to estimate the odds ratios of prevalentcardiovascular disease associated with self‐reported diabetes, and with measured random bloodglucose levels among participants with no history of diabetes, adjusting simultaneously for age,sex, area, education, smoking, alcohol, blood pressure and physical activity. |
| PubMedID- 26078978 | The presence of macrovascular disease in patients with type 2 diabetes may be a confounding factor when assessing an association of vitamin d with other conditions. |
| PubMedID- 21447669 | As the results of the heart2d trial suggest that glucose variability is not a risk factor for cardiovascular diseases in patients with type 2 diabetes treated with insulin (1,2), several “burning” questions can be raised, why could glucose variability be a risk factor for cardiovascular diseases in patients with type 2 diabetes who are treated with oral hypoglycemic agents alone, but not in those who are treated with insulin, and does insulin per se neutralize the deleterious effects of glycemic variability on oxidative stress in patients treated with it? |
| PubMedID- 22301122 | For example, cardiac autonomic dysfunction is a risk factor for cardiovascular diseases in diabetes (3,17) and is usually diagnosed according to impaired hrv (1,18). |
| PubMedID- 23745805 | Micrornas: biomarkers for cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 24688629 | In fact, it may be that this rapid aging of apoa-1, a key protein in lipoprotein metabolism, causes a higher risk of macrovascular disease in persons with type 1 diabetes . |